Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › albendazole

albendazole

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of albendazole

11 trials tracked of albendazole: 6 in phase 3 or 4 and 4 with published results. The most-cited published study has 141 citations.

11Trials tracked
6Phase 3 & 4
0Recruiting
4With published results
Phase distribution
Phase 3 6 Phase 2 4 Phase 1 1
  1. Phase 3 Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy Study Completed · 141 cited
  2. Phase 3 Efficacy and Safety of IVM/ALB Co-administration Completed · 73 cited
  3. Phase 3 Moxidectin for LF, Cote d'Ivoire (DOLF) Completed · 10 cited
  4. Phase 3 Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths (STH) Completed · 5 cited
  5. Phase 3 Safety of a Single Dose of Moxidectin Compared With Ivermectin in Individuals Living in Onchocerciasis Endemic Areas and in Individuals Living in Onchocerciasis Endemic Areas With High Levels of Lymphatic Filariasis Co-endemicity Receiving Concomitant Albendazole Completed
  6. Phase 3 Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ) Completed
Show 5 more trials
  1. Phase 2 Albendazole Plus High Dose Ivermectin for Trichuriasis in Pediatric Patients Completed
  2. Phase 2 Efficacy of Na-GST-1/Alhydrogel Hookworm Vaccine Assessed by Controlled Challenge Infection Completed
  3. Phase 2 Albendazole Dose Finding and Pharmacokinetics in Children and Adults Completed
  4. Phase 2 Effect of Albendazole Dose on Treatment of Lymphatic Filariasis Completed
  5. Phase 1 Bioequivalence Study of Albendazole 400 mg Tablets in Chinese Population Completed

Showing the 11 most-cited and recently-updated of 11 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Meta-analysis shows integrated MDA reduces yaws attendances in Papua New Guinea
Infectious Disease Meta-analysis
Meta-analysis shows integrated MDA reduces yaws attendances in Papua New Guinea Four-drug treatment lowered yaws cases in Papua New Guinea communities significantly
This comparative observational study and systematic review with network meta-analysis evaluates yaws control strategies in under-reached com…
A new review shows that giving four medicines together greatly reduced yaws cases in Papua New Guinea. People saw fewer skin problems and fe…
May 14, 2026
Open cyst deroofing plus albendazole shows low recurrence in pediatric cystic echinococcosis
Orthopedics & Sports Medicine Cohort
Open cyst deroofing plus albendazole shows low recurrence in pediatric cystic echinococcosis Kids in Jordan get surgery for parasitic cysts with low return rates
This retrospective cohort study of 41 pediatric patients in Northern Jordan found that open cyst deroofing combined with albendazole resulte…
A new look at kids in Jordan shows surgery and medicine can stop dangerous parasites from returning after treatment
Frontiers Apr 29, 2026
Cross-sectional review of mass drug administration impact on lymphatic filariasis elimination in Nepal
Infectious Disease
Cross-sectional review of mass drug administration impact on lymphatic filariasis elimination in Nepal Mass drug administration reduces lymphatic filariasis in most Nepal districts
This cross-sectional epidemiological monitoring survey review assesses lymphatic filariasis transmission in six endemic districts of Nepal f…
A survey of over 7,000 people in Nepal found that mass drug administration lowered infection rates in most areas, though three sites still n…
medRxiv Apr 24, 2026